*	OR T1 T2
R1	Has_qualifier Arg1:T3 Arg2:T4	
R2	multi Arg1:T4 Arg2:T5	
R3	Has_value Arg1:T6 Arg2:T8	
R4	Has_negation Arg1:T6 Arg2:T7	
R5	Has_temporal Arg1:T10 Arg2:T12	
R6	Has_temporal Arg1:T11 Arg2:T12	
*	OR T9 T10 T11
*	OR T13 T14
R7	Has_temporal Arg1:T16 Arg2:T17	
R8	multi Arg1:T21 Arg2:T22	
R9	Has_mood Arg1:T21 Arg2:T20	
*	OR T25 T27 T24 T28
R10	Has_qualifier Arg1:T33 Arg2:T34	
R11	Has_temporal Arg1:T33 Arg2:T26	
R12	Has_mood Arg1:T37 Arg2:T38	
R13	Has_temporal Arg1:T35 Arg2:T39	
R14	Has_negation Arg1:T36 Arg2:T40	
*	OR T35 T37
R15	multi Arg1:T37 Arg2:T41	
R16	AND Arg1:T35 Arg2:T36	
R17	Has_qualifier Arg1:T42 Arg2:T43	
R18	multi Arg1:T47 Arg2:T48	
R19	causal Arg1:T51 Arg2:T52	
R20	causal Arg1:T54 Arg2:T55	
R21	Has_index Arg1:T56 Arg2:T57	
R22	Has_temporal Arg1:T55 Arg2:T56	
R23	causal Arg1:T53 Arg2:T55	
R24	Has_negation Arg1:T60 Arg2:T59	
R25	AND Arg1:T58 Arg2:T60	
T1	Condition 14 27	hemoglobin SC
T2	Condition 31 46	SB+ thalassemia
T3	Procedure 68 87	transfusion program
T4	Qualifier 60 67	chronic
T5	Multiplier 60 67	chronic
T6	Procedure 116 132	RBC transfusions
T7	Negation 133 144	cannot have
T8	Value 145 166	>15% adult hemoglobin
T9	Condition 194 197	HIV
T10	Condition 206 217	hepatitis B
T11	Condition 221 232	hepatitis C
T12	Temporal 199 205	active
T13	Condition 234 242	Pregnant
T14	Observation 246 260	breast feeding
T15	Person 261 266	women
T16	Condition 298 308	malignancy
T17	Temporal 287 294	history
T18	Condition 436 448	disease-free
T19	Temporal 449 469	for at least 5 years
T20	Mood 514 522	low risk
T21	Condition 527 556	recurrence of that malignancy
T22	Condition 541 556	that malignancy
T23	Subjective_judgement 478 504	deemed by the investigator
T24	Condition 682 703	breast cancer in situ
T25	Condition 670 678;689 703	cervical cancer in situ
T26	Temporal 645 668	within the past 5 years
T27	Condition 723 758	squamous cell carcinoma of the skin
T28	Condition 709 719;737 758	basal cell carcinoma of the skin
T29	Grammar_Error 596 608	are eligible
T30	Negation 596 608	are eligible
T31	Mood 612 621	diagnosed
T32	Mood 626 644	adequately treated
T33	Procedure 637 644	treated
T34	Qualifier 626 636	adequately
T35	Condition 787 797	thrombosis
T36	Condition 826 845	sickle cell disease
T37	Condition 860 875	thrombotic risk
T38	Mood 851 859;871 875	enhanced risk
T39	Temporal 776 783	history
T40	Negation 815 825	other than
T41	Condition 860 870	thrombotic
T42	Condition 902 912	infections
T43	Qualifier 891 901	unresolved
T44	Condition 937 955	medical conditions
T45	Qualifier 967 997	compromise study participation
T46	Post-eligibility 914 997	Severe or uncontrolled medical conditions that could compromise study participation
T47	Drug 1011 1043	fetal hemoglobin inducing agents
T48	Qualifier 1011 1016	fetal
T49	Post-eligibility 1045 1200	Subjects on any other experimental treatment within 90 days of the first dose of study drug or who have not recovered from the side effects of such therapy
T50	Context_Error 1045 1200	Subjects on any other experimental treatment within 90 days of the first dose of study drug or who have not recovered from the side effects of such therapy
T51	Condition 1208 1225	allergic reaction
T52	Drug 1231 1260	histone deacetylase inhibitor
T53	Drug 1289 1302	valproic acid
T54	Procedure 1307 1316	treatment
T55	Condition 1320 1328	epilepsy
T56	Temporal 1329 1357	within 30 days of enrollment
T57	Reference_point 1347 1357	enrollment
T58	Drug 1390 1405	HDAC inhibitors
T59	Negation 1406 1416	other than
T60	Drug 1417 1430	valproic acid
